Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesEpidemiological Features and Costs of Herpes Zoster in Taiwan: a National Study 2000 to 2006
Acta Dermato-Venereologica, 10/27/09
Jih JS et al. – People with older age, diabetes, and immunocompromising conditions were at higher risk of developing zoster and post–herpetic neuralgia. The overall hospitalization rate for zoster was 16.1 cases per 100,000 person–years. The cost for each home care case and per hospitalized case were approximately €53.30 and €1224.70, respectively.
Related Articles
Increased Risk of Stroke After a Herpes Zoster Attack. A Population-Based Follow-Up Study
Stroke, 10/12/09
Relevance Score: 68%
Cutaneous Herpes Zoster and Implantable Pulse Generator
Neuromodulation, 11/02/09
Relevance Score: 67%
A 9 year follow up of post herpetic neuralgia and predisposing factors in elderly patients following herpes zoster
Journal of Infection, 10/12/09
Relevance Score: 67%
Herpes zoster ophthalmicus
Expert Review of Ophthalmology, 10/08/09
Relevance Score: 67%
Treatment of Herpes Zoster and Postherpetic Neuralgia
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 10/19/09
Relevance Score: 66%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/14/09
Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial
British Journal of Dermatology, 12/14/09
Topical photodynamic therapy is immunosuppressive in humans
British Journal of Dermatology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor